Selection Criteria for Initiation and Renewal of Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients With Prostate Cancer: A French Prospective Observational Study
Therapeutic Advances in Urology- United States
doi 10.1177/1756287214542418
Full Text
Abstract
Available in
Categories
Date
July 25, 2014
Authors
Publisher
SAGE Publications